Data Updates on BCMA-Targeting Bispecific Antibodies in R/R MM Treatment

Video

Dr Cindy Varga discusses recent data on the FDA-approved agent teclistamab, a bispecific antibody for patients with relapsed/refractory multiple myeloma.

Related Videos
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Cesar Rodriguez, MD, and Frits van Rhee, MD, PhD
A panel of 4 experts on multiple myeloma
Cesar Rodriguez, MD, and Frits van Rhee, MD, PhD
A panel of 4 experts on multiple myeloma
4 KOLs are featured in this program.
4 KOLs are featured in this program.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Related Content